17.56
0.12 (0.69%)
| Penutupan Terdahulu | 17.44 |
| Buka | 17.68 |
| Jumlah Dagangan | 100,797 |
| Purata Dagangan (3B) | 1,156,042 |
| Modal Pasaran | 934,665,152 |
| Harga / Pendapatan (P/E TTM) | 13.72 |
| Harga / Pendapatan (P/E Ke hadapan) | 78.12 |
| Harga / Jualan (P/S) | 3.00 |
| Harga / Buku (P/B) | 3.06 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | 17.92% |
| Margin Operasi (TTM) | -9.46% |
| EPS Cair (TTM) | 1.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.98% |
| Nisbah Semasa (MRQ) | 4.11 |
| Aliran Tunai Operasi (OCF TTM) | 26.78 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 29.89 M |
| Pulangan Atas Aset (ROA TTM) | -5.20% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Bercampur |
| Diagnostics & Research (Global) | Menaik | Bercampur | |
| Stok | CareDx, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.30 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.22% |
| % Dimiliki oleh Institusi | 99.39% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Gagnon Securities Llc | 30 Sep 2025 | 1,729,425 |
| Julat 52 Minggu | ||
| Median | 25.00 (42.37%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 06 Nov 2025 | 25.00 (42.37%) | Beli | 15.01 |
| 23 Sep 2025 | 22.00 (25.28%) | Beli | 15.57 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| NOVACK JEFFREY ADAM | - | 19.41 | -7,293 | -141,557 |
| Jumlah Keseluruhan Kuantiti Bersih | -7,293 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -141,557 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 19.41 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NOVACK JEFFREY ADAM | Pegawai | 04 Dec 2025 | Jual automatik (-) | 7,293 | 19.41 | 141,557 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |